Who
Ann D. Rhoads
Director
Company insider
Files Form 4 as: Director, QuidelOrtho; Director, Globus Medical; Director, Repare Therapeutics; Director, iTeos Therapeutics; Director, Quidel Corp /de/; Director, Evoke Pharma; Chief Financial Officer, Forty Seven; Director, Iridex.
In numbers
- Trades disclosed
- 157
- Buys
- 4
- Sells
- 8
- Bought
- $322K
- Sold
- $3.3M
- Companies
- 10
- Companies where not an officer
- 8
- First trade
- 18 May 2006
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,532 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,698 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —369 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,532 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,698 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —369 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Code M | $657K25,000 at $26.27 | filing |
| 4 Jun 2026filed 8 Jun 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Code M | $657K25,000 at $26.27 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —1,173 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —234 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,173 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,173 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —234 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —234 at $0.00 | filing |
News
Financial Comparison: LivaNova (NASDAQ:LIVN) vs. QuidelOrtho (NASDAQ:QDEL)QDEL · themarketsdaily.com · 17 Oct 2026QuidelOrtho Grants Stock Units Covering 50,323 Shares to Two New HiresQDEL · econotimes.com · 16 Oct 2026Analyzing LivaNova (NASDAQ:LIVN) & QuidelOrtho (NASDAQ:QDEL)QDEL · themarketsdaily.com · 16 Oct 2026
0 headlines in the last 90 days name Ann D. Rhoads; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.